MHRA approves Leqselvi for severe alopecia areata
Around 30% of patients saw 80% more scalp hair after 24 weeks of treatment
Read More
Mar 13, 2026 | News, Regulatory
Around 30% of patients saw 80% more scalp hair after 24 weeks of treatment
Read MoreMar 13, 2026 | News, Healthcare
Minister Peter Burke, and representatives from IDA Ireland met with the company’s leadership team
Read MoreMar 12, 2026 | News, Regulatory
Sotyktu is the first TYK2 inhibitor approved for active psoriatic arthritis
Read MoreThe rare neurodegenerative disorder has no cure and no approved treatments
Read MoreMar 9, 2026 | News, Regulatory
The approval was based on phase 3 data showing survival rates of 83.3% after three years
Read MoreMar 6, 2026 | News, Healthcare
The US state investment will go to 33 community-based organisations
Read MoreMar 4, 2026 | News, Regulatory
The autoimmune disease affects approximately three to five million people globally
Read MoreMar 3, 2026 | News, Healthcare
Construction is expected to be completed in phases from the end of 2027 into 2028
Read MoreMar 2, 2026 | News, Healthcare
The draft guidance specifically discusses genome editing and RNA-based therapies
Read MoreFeb 27, 2026 | News, Healthcare
The study finds that healthcare settings are a leading source of stigma for people living with rare conditions
Read MoreFeb 26, 2026 | News, Healthcare
The companies aim to develop next-generation oral medicines for obesity and diabetes
Read MorePH has a five‑year survival rate of only around 50% and affects up to 82 million people worldwide
Read More
